Lux Capital

About

Lux Capital is a venture capital firm focused on frontier science and deep technology, founded in 2000 by Peter Hébert, Josh Wolfe, and Robert Paull ¹². The firm is headquartered in New York City with a second office in Menlo Park, California ³. Neither founder had a prior track record, wealthy family, or deep network when they started the firm in March 2000, just as the tech bubble was about to burst ².

The firm manages over $7 billion in assets and employs more than 40 full-time professionals ³. Lux invests across a wide range, from $100,000 to $100 million per deal ³. In January 2026, Lux closed its ninth fund at $1.5 billion, the largest in the firm’s history, focused on frontier science and defense technology ⁴. The prior fund, Lux Ventures VIII, closed at $1.15 billion in 2023 ¹. Early backers of the firm included financiers Stanley Druckenmiller, Ken Griffin, and Peter G. Peterson, though most current LPs are endowments and nonprofit institutions ².

In 2025, Lux launched Lux Labs, a $100 million initiative to fund academic research in science-driven innovation ¹. Notable portfolio exits include Auris Health (acquired by Johnson & Johnson for $6.1 billion in 2019), Chronosphere (acquired by Palo Alto Networks for $3.35 billion in 2025), and CTRL-Labs (acquired by Meta) ¹⁵.

Stated Thesis

Lux Capital’s tagline is “We believe before others understand” ³. The firm publicly describes its focus as investing in “transformational change rather than incremental progress,” targeting “leaders with a vision, who see a radically different future” ³.

Co-founder Josh Wolfe has articulated a “100-0-100 investment philosophy”: the first 100 represents certainty that Lux will invest in “the most cutting-edge, crazy things,” the 0 represents intellectual humility (“I have no idea what those things will be”), and the final 100 is confidence in knowing where to find them — “at the edge of our already cutting-edge companies” ⁶.

Wolfe has described Lux’s origins in areas “we thought were totally neglected” — specifically the “chemistry, physics, and material science departments” ⁶. The firm states it aims to “turn science fiction into science fact” by backing companies at the intersection of science and finance ⁶.

Inferred Thesis

Based on the 24 portfolio companies listed on Lux Capital’s website as of March 2026 ⁷, the following patterns emerge. Note: this represents a subset of an estimated 287 total portfolio organizations ⁵, so percentages reflect only the most prominently featured investments.

Sector distribution (24 featured companies): - AI/ML and infrastructure: 8 of 24 (33%) — Hugging Face, Cognition, Applied Compute, Runway, Sakana AI, Together.xyz, Modal, Databricks - Biotech/healthcare: 6 of 24 (25%) — Eikon Therapeutics, Kallyope, Recursion Pharma, Aera Therapeutics, A-Alpha Bio, Auris Health - Defense/aerospace: 3 of 24 (13%) — Anduril, Applied Intuition, Hadrian - Enterprise/infrastructure: 4 of 24 (17%) — Benchling, Chronosphere, Matterport, Ramp - Other (sensing, chemistry): 3 of 24 (13%) — Osmo, Erebor, Physical Intelligence

Stage distribution: Lux invests primarily at Series A and Seed, with 107 Series A investments (average round size $27.9M) and 102 Seed investments (average round size $15.8M) historically ⁵.

Geographic focus: Primarily U.S.-based companies, concentrated in New York and Silicon Valley ¹³.

Notable pattern: Defense technology is a significant and growing focus. Anduril ($30.5 billion valuation) and Applied Intuition ($15 billion valuation) are the firm’s top portfolio companies by valuation ⁴. The firm positioned itself in defense technologies years before geopolitical shifts made the sector broadly attractive ⁴.

Co-investor patterns and portfolio unicorns: The portfolio includes 26 unicorns as of January 2026, with 12 IPOs and 59 acquisitions ⁵.

Portfolio

This table represents approximately 9% of Lux Capital’s estimated 287 portfolio organizations ⁵. Years shown are approximate based on available data.

In Their Own Words

“Lux started with this sort of definitional focus on areas we thought were totally neglected. Let’s go after the chemistry, physics, and material science departments.” — Josh Wolfe, Lux Capital co-founder ⁶

“I like to find areas where there’s really high scientific and technical complexity.” — Josh Wolfe ⁶

“We like to think differently, but the truth is, we want people to agree with us… but later.” — Josh Wolfe ⁶

“I’m both an optimist about the endless frontier of technological possibility and a realist who believes failure comes from a failure to imagine failure.” — Josh Wolfe ²

“Try to understand what the consensus is, find a variant perception, something that people aren’t thinking about.” — Josh Wolfe ⁶

“What is predictive of financial returns is how much capital is going into the sector. The more capital that is going into the sector, the worse financial returns will be.” — Josh Wolfe ⁶

What Founders Say

No independently sourced founder testimonials found. Lux Capital’s portfolio companies have spoken positively about the firm’s hands-on advisory approach and network access ¹, but specific verified founder quotes attributable to named individuals could not be independently confirmed at this time.

Sources